**Core Concept:** Antibiotics that possess additional anti-inflammatory and immunomodulatory activities are called "biological response modifiers" or "immunomodulatory antibiotics". They impact the immune system by targeting various cellular and molecular components involved in inflammation and infection.

**Why the Correct Answer is Right:** Linezolid is a broad-spectrum antibiotic that primarily targets Gram-positive bacteria. However, it also exhibits immunomodulatory activity. It inhibits bacterial protein synthesis by binding to the 23S rRNA of bacterial 50S ribosomal subunit, which is not present in eukaryotic ribosomes. This unique mode of action results in the suppression of bacterial growth and, at the same time, inhibits the host immune response by blocking the production of pro-inflammatory cytokines and chemokines, thus reducing inflammation and tissue damage.

**Why Each Wrong Option is Incorrect:**

A. Penicillin (e.g., penicillin G) is a beta-lactam antibiotic that primarily targets Gram-positive bacteria. It does not possess immunomodulatory activity, making it an incorrect choice.

B. Vancomycin is a glycopeptide antibiotic that primarily targets Gram-positive bacteria. It too does not have immunomodulatory activity, making it an incorrect choice.

C. Linezolid is the correct answer, as mentioned above. It demonstrates immunomodulatory activity due to its unique mode of action.

D. Clindamycin is a macrolide antibiotic that primarily targets Gram-positive bacteria. It has immunomodulatory activity, but it is not as potent as Linezolid.

**Clinical Pearl:** Immunomodulatory antibiotics like Linezolid have potential applications in the treatment of severe infections along with underlying inflammation, as they can target both bacterial pathogens and modulate the host immune response. However, they should be used cautiously due to their potential side effects, including myelosuppression and neurotoxicity.